{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:59:15Z","timestamp":1765727955409,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU-TB 02.709"],"award-info":[{"award-number":["TTU-TB 02.709"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forschungszentrum Borstel - Leibniz Lungenzentrum"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40265-024-02122-4","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T13:18:27Z","timestamp":1735478307000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis"],"prefix":"10.1007","volume":"85","author":[{"given":"A.","family":"Rauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1911-0379","authenticated-orcid":false,"given":"N.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. T.","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stoycheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schmiedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kalsdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"2122_CR1","volume-title":"Global tuberculosis report 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022."},{"key":"2122_CR2","first-page":"2022","volume-title":"WHO operational handbook on tuberculosis. Module 4: treatment\u2014drug-resistant tuberculosis treatment 2022 update","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO operational handbook on tuberculosis. Module 4: treatment\u2014drug-resistant tuberculosis treatment 2022 update. Geneva: World Health Organization; 2022. p. 2022."},{"issue":"51 Suppl 2","key":"2122_CR3","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1086\/653520","volume":"15","author":"JA Paladino","year":"2010","unstructured":"Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;15(51 Suppl 2):S198-208.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2122_CR4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1017\/ice.2021.22","volume":"42","author":"GH Loesch","year":"2021","unstructured":"Loesch GH, Cruz JAW, Gasparetto J, Oliveira DDS, Telles JP, Tuon FF. Cost minimization analysis of outpatient parenteral\/oral antibiotic therapy at a trauma hospital: Public health system. Infect Control Hosp Epidemiol. 2021;42(12):1445\u201350.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"2122_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10096-017-2944-5","volume":"36","author":"L Saillen","year":"2017","unstructured":"Saillen L, Arensdorff L, Moulin E, Voumard R, Cochet C, Boillat-Blanco N, et al. Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps. Eur J Clin Microbiol Infect Dis. 2017;36(8):1387\u201392.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2122_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cid\/cix733","volume":"66","author":"SC Keller","year":"2018","unstructured":"Keller SC, Williams D, Gavgani M, Hirsch D, Adamovich J, Hohl D, et al. Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2018;66(1):11\u20139.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2122_CR7","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/jac\/dky294","volume":"73","author":"O Mansour","year":"2018","unstructured":"Mansour O, Heslin J, Townsend JL. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates. J Antimicrob Chemother. 2018;73(11):3181\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2122_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/cid\/ciz150","volume":"70","author":"DL Palms","year":"2020","unstructured":"Palms DL, Jacob JT. Close patient follow-up among patients receiving outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2020;70(1):67\u201374.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2122_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/cid\/cit920","volume":"58","author":"GM Allison","year":"2014","unstructured":"Allison GM, Muldoon EG, Kent DM, Paulus JK, Ruthazer R, Ren A, et al. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis. 2014;58(6):812\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2122_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/thoraxjnl-2018-212675","volume":"75","author":"DB Cohen","year":"2020","unstructured":"Cohen DB, Mbendera K, Maheswaran H, Mukaka M, Mangochi H, Phiri L, et al. Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trial. Thorax. 2020;75(1):64\u201371.","journal-title":"Thorax"},{"key":"2122_CR11","doi-asserted-by":"crossref","unstructured":"Al Shareef HJ, Al Harbi A, Alatawi Y, Aljabri A, Al-Ghanmi MA, Alzahrani MS, et al. Evaluate the effectiveness of outpatient parenteral antimicrobial therapy (OPAT) program in Saudi Arabia: a retrospective study. Antibiotics (Basel). 2022;11(4).","DOI":"10.3390\/antibiotics11040441"},{"key":"2122_CR12","doi-asserted-by":"crossref","unstructured":"Oliveira PR, Felix Cda S, Carvalho VC, Giovani AM, Reis RS, Beraldo M, et al. Outpatient parenteral antimicrobial therapy for orthopedic infections\u2014a successful public healthcare experience in Brazil. Braz J Infect Dis. 2016;20(3):272\u20135.","DOI":"10.1016\/j.bjid.2016.03.005"},{"key":"2122_CR13","doi-asserted-by":"crossref","unstructured":"Hanumunthadu B, Harrison T, Mathew D, Cotter M. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: successes and complications on outpatient parenteral antimicrobial therapy at a london teaching hospital between 2009 and 2016. Open Forum Infect Dis. 2016;3(suppl_1).","DOI":"10.1093\/ofid\/ofw172.421"},{"issue":"1","key":"2122_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1183\/09031936.00188313","volume":"44","author":"C Lange","year":"2014","unstructured":"Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, et al. Management of patients with multidrug-resistant\/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44(1):23\u201363.","journal-title":"Eur Respir J"},{"key":"2122_CR15","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. 2021 update ed. Geneva: World Health Organization; 2021."},{"issue":"1","key":"2122_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jcpt.12465","volume":"42","author":"G Suleyman","year":"2017","unstructured":"Suleyman G, Kenney R, Zervos MJ, Weinmann A. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic. J Clin Pharm Ther. 2017;42(1):39\u201343.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"2122_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/jac\/dkac047","volume":"77","author":"M Gilchrist","year":"2022","unstructured":"Gilchrist M, Barr D, Drummond F, Muir A, Williams J, Scriven J, et al. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015\u201319). J Antimicrob Chemother. 2022;77(5):1481\u201390.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2122_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/jac\/dkt512","volume":"69","author":"NK Shrestha","year":"2014","unstructured":"Shrestha NK, Mason P, Gordon SM, Neuner E, Nutter B, O\u2019Rourke C, et al. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study. J Antimicrob Chemother. 2014;69(5):1407\u201315.","journal-title":"J Antimicrob Chemother"},{"issue":"9\u201310","key":"2122_CR19","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/jocn.12376","volume":"23","author":"K Eaves","year":"2014","unstructured":"Eaves K, Thornton J, Chapman AL. Patient retention of training in self-administration of intravenous antibiotic therapy in an outpatient parenteral antibiotic therapy service. J Clin Nurs. 2014;23(9\u201310):1318\u201322.","journal-title":"J Clin Nurs"},{"issue":"1","key":"2122_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jac\/dkn152","volume":"62","author":"M Gilchrist","year":"2008","unstructured":"Gilchrist M, Franklin BD, Patel JP. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother. 2008;62(1):177\u201383.","journal-title":"J Antimicrob Chemother"},{"key":"2122_CR21","doi-asserted-by":"crossref","unstructured":"Billmeyer KN, Ross JK, Hirsch EB, Evans MD, Kline SE, Galdys AL. Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort. Ther Adv Infect Dis. 2023;10:20499361231179668.","DOI":"10.1177\/20499361231179668"},{"issue":"4","key":"2122_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1513236","volume":"375","author":"AH Diacon","year":"2016","unstructured":"Diacon AH, van der Merwe L, Barnard M, von Groote-Bidlingmaier F, Lange C, Garcia-Basteiro AL, et al. beta-Lactams against tuberculosis-new trick for an old dog? N Engl J Med. 2016;375(4):393\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"2122_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jinf.2023.01.039","volume":"86","author":"N Koehler","year":"2023","unstructured":"Koehler N, Andres S, Merker M, Dreyer V, John A, Kuhns M, et al. Pretomanid-resistant tuberculosis. J Infect. 2023;86(5):520\u20134.","journal-title":"J Infect"},{"issue":"3","key":"2122_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jama.1982.03330030042023","volume":"248","author":"DM Poretz","year":"1982","unstructured":"Poretz DM, Eron LJ, Goldenberg RI, Gilbert AF, Rising J, Sparks S, et al. Intravenous antibiotic therapy in an outpatient setting. JAMA. 1982;248(3):336\u20139.","journal-title":"JAMA"},{"issue":"10","key":"2122_CR25","first-page":"1480","volume":"38","author":"JP Swenson","year":"1981","unstructured":"Swenson JP. Training patients to administer intravenous antibiotics at home. Am J Hosp Pharm. 1981;38(10):1480\u20133.","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"2122_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jcpt.13550","volume":"47","author":"S Karimaghaei","year":"2022","unstructured":"Karimaghaei S, Rao A, Chijioke J, Finch N, Nigo M. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States. J Clin Pharm Ther. 2022;47(2):211\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"2122_CR27","doi-asserted-by":"crossref","unstructured":"Stoorvogel HH, Hulscher M, Wertheim HFL, Yzerman EPF, Scholing M, Schouten JA, et al. Current practices and opportunities for outpatient parenteral antimicrobial therapy in hospitals: a national cross-sectional survey. Antibiotics (Basel). 2022;11(10).","DOI":"10.3390\/antibiotics11101343"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-024-02122-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:00:35Z","timestamp":1737079235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-024-02122-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1007\/s40265-024-02122-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"type":"print","value":"0012-6667"},{"type":"electronic","value":"1179-1950"}],"subject":[],"published":{"date-parts":[[2024,12,29]]},"assertion":[{"value":"3 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by Projekt DEAL. This work was supported by the German Center for Infection Research under grant agreement\u00a0TTU-TB\u00a002.709.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request. Data are located in controlled access data storage at the Research Center Borstel, Leibniz Lung Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Niklas K\u00f6hler reports receiving project grants from the Schleswig-Holstein Society for Prevention and Control of Tuberculosis and Pulmonary Diseases for work outside the scope of the submitted work. Christoph Lange reports a grant from the German Center for Infection Research. He holds leadership roles in TBNET and The International Union against TB and Lung Diseases and received honoraria from GSK, Gilead, Insmed, and MedUpdate for speaking engagements, outside the scope of the submitted work. Barbara Kalsdorf received speaker honoraria for lectures from Insmed Germany GMBH, and Astra Zeneca Deutschland, as well as support for attending meetings and\/or travel from Astra Zeneca Deutschland, GSK Deutschland, and Boehringer Ingelheim Deutschland, outside the scope of the submitted work. Anika Rauch, Thomas Theo Brehm, Nika Zielinski, Krista Stoycheva, Christina Maier, Laura B\u00f6ttcher, Inna Friesen, Dagmar Schaub, Maja Reimann and Stefan Schmiedel each report no conflict of interest related to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Anika Rauch: conceptualisation, methodology, validation, formal analysis, investigation, data curation, writing\u2014original draft, visualisation, project administration. Niklas K\u00f6hler: conceptualisation, methodology, validation, formal analysis, investigation, data curation, writing\u2014original draft, visualisation, project administration. Thomas Theo Brehm: methodology, formal analysis, investigation, writing\u2014original draft, supervision. Nika Zielinski: methodology, software, formal analysis, investigation, data curation, writing\u2014original draft, visualisation. Krista Stoycheva: methodology, investigation, writing\u2014review and editing, project administration. Christina Maier: conceptualisation, validation, formal analysis, investigation, resources, data curation, writing\u2014original draft. Laura B\u00f6ttcher: conceptualisation, validation, investigation, resources, data curation, writing\u2014original draft. Inna Friesen: validation, resources, writing\u2014review and editing, supervision. Dagmar Schaub: formal analysis, investigation, data curation, writing\u2014review and editing, project administration. Maja Reimann: conceptualisation, methodology, validation, formal analysis, investigation, data curation, writing\u2014original draft, visualisation, supervision. Stefan Schmiedel: conceptualisation, methodology, writing\u2014review and editing, visualisation, supervision. Christoph Lange: conceptualisation, methodology, investigation, resources, writing\u2014original draft, supervision, project administration, funding acquisition. Barbara Kalsdorf: conceptualisation, methodology, investigation, resources, writing\u2014original draft, supervision, project administration.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"Ethical approval was waived by the local Ethics Committee of University of L\u00fcbeck (24-215) in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}